Biochemical characterization of l-asparagine synthetase from Streptococcus thermophilus and its application in the enzymatic synthesis of β-aspartyl compounds.
- 2024-09
- Journal of bioscience and bioengineering 138(3)
- PubMed: 38981802
- DOI: 10.1016/j.jbiosc.2024.06.001
Study Design
- Methods
- Recombinant StAS was expressed in Escherichia coli BL21(DE3); biochemical characterization of asparagine synthetase (AS) from Streptococcus thermophilus NBRC 13957 and enzymatic synthesis of β-aspartyl compounds using StAS, coupled with an ATP-regeneration system using polyphosphate kinase from Deinococcus proteoliticus NBRC 101906.
β-Aspartyl compounds, such as β-aspartyl hydroxamate (serine racemase inhibitor), β-aspartyl-l-lysine (moisture retention), and β-aspartyl-l-tryptophan (immunomodulator) are physiologically active compounds. There is limited literature on the development of effective methods of production of β-aspartyl compounds. In this study, we describe the biochemical characterization of asparagine synthetase (AS) from Streptococcus thermophilus NBRC 13957 (StAS) and the enzymatic synthesis of β-aspartyl compounds using StAS. Recombinant StAS was expressed in Escherichia coli BL21(DE3) and it displayed activity towards hydroxylamine, methylamine, ethylamine, and ammonia, as acceptors of the β-aspartyl moiety. StAS exhibited higher activity toward hydroxylamine and ethylamine as acceptor substrates compared with the enzymes from Lactobacillus delbrueckii NBRC 13953, Lactobacillus reuteri NBRC 15892, and E. coli. The coupling of the synthesis of β-aspartyl compounds by StAS with an ATP-regeneration system using polyphosphate kinase from Deinococcus proteoliticus NBRC 101906 displayed an approximately 2.5-fold increase in the production of β-aspartylhydroxamate from 1.06 mM to 2.53 mM after a 76-h reaction.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|